Management of insomnia (Q28146044)

Journal of the American Pharmacists Association

PubMed

September 1999

0 references

published in

0 references

volume

39

0 references

page(s)

688-96; quiz 713-4

0 references

688-696

0 references

issue

5

0 references

1 reference

https://api.crossref.org/works/10.1016%2FS1086-5802%2815%2930354-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS1086-5802%2815%2930354-5

1 reference

7 January 2021

Prevalence of sleep disorders in the Los Angeles metropolitan area

1 reference

https://api.crossref.org/works/10.1016%2FS1086-5802%2815%2930354-5

7 January 2021

Insomnia and its treatment. Prevalence and correlates.

1 reference

https://api.crossref.org/works/10.1016%2FS1086-5802%2815%2930354-5

7 January 2021

Prevalence, burden, and treatment of insomnia in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS1086-5802%2815%2930354-5

7 January 2021

Relationship between sleepiness and general health status

1 reference

https://api.crossref.org/works/10.1016%2FS1086-5802%2815%2930354-5

7 January 2021

Sleep problems in the community elderly as predictors of death and nursing home placement

1 reference

https://api.crossref.org/works/10.1016%2FS1086-5802%2815%2930354-5

7 January 2021

Sleep complaints among elderly persons: an epidemiologic study of three communities.

1 reference

https://api.crossref.org/works/10.1016%2FS1086-5802%2815%2930354-5

7 January 2021

Anxiety disorders and insomnia in geriatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS1086-5802%2815%2930354-5

7 January 2021

Management of insomnia

1 reference

https://api.crossref.org/works/10.1016%2FS1086-5802%2815%2930354-5

7 January 2021

Alleviation of sleep maintenance insomnia with timed exposure to bright light.

1 reference

https://api.crossref.org/works/10.1016%2FS1086-5802%2815%2930354-5

7 January 2021

Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1086-5802%2815%2930354-5

7 January 2021

Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS1086-5802%2815%2930354-5

7 January 2021

Pharmacokinetic determinants of dynamic differences among three benzodiazepine hypnotics. Flurazepam, temazepam, and triazolam.

1 reference

https://api.crossref.org/works/10.1016%2FS1086-5802%2815%2930354-5

7 January 2021

Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS1086-5802%2815%2930354-5

7 January 2021

Effects of drugs on sleep

1 reference

https://api.crossref.org/works/10.1016%2FS1086-5802%2815%2930354-5

7 January 2021

Quazepam and flurazepam: long-term use and extended withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS1086-5802%2815%2930354-5

7 January 2021

Psychotropic drug use and the risk of hip fracture

1 reference

https://api.crossref.org/works/10.1016%2FS1086-5802%2815%2930354-5

7 January 2021

Interaction of triazolam and ketoconazole

1 reference

https://api.crossref.org/works/10.1016%2FS1086-5802%2815%2930354-5

7 January 2021

The effect of ingestion time interval on the interaction between itraconazole and triazolam

1 reference

https://api.crossref.org/works/10.1016%2FS1086-5802%2815%2930354-5

7 January 2021

Triazolam is ineffective in patients taking rifampin

1 reference

https://api.crossref.org/works/10.1016%2FS1086-5802%2815%2930354-5

7 January 2021

Diltiazem enhances the effects of triazolam by inhibiting its metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1086-5802%2815%2930354-5

7 January 2021

Hypnotic Efficacy of Triazolam: Sleep Laboratory Evaluation of Intermediate-Term Effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FS1086-5802%2815%2930354-5

7 January 2021

Report of the Institute of Medicine Committee on the Efficacy and Safety of Halcion

1 reference

https://api.crossref.org/works/10.1016%2FS1086-5802%2815%2930354-5

7 January 2021

Zolpidem: distinct from triazolam?

1 reference

https://api.crossref.org/works/10.1016%2FS1086-5802%2815%2930354-5

7 January 2021

Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS1086-5802%2815%2930354-5

7 January 2021

Minimal rebound insomnia after treatment with 10-mg zolpidem

1 reference

https://api.crossref.org/works/10.1016%2FS1086-5802%2815%2930354-5

7 January 2021

Sleepwalking associated with zolpidem

1 reference

https://api.crossref.org/works/10.1016%2FS1086-5802%2815%2930354-5

7 January 2021

Tolerance and withdrawal with zolpidem

1 reference

https://api.crossref.org/works/10.1016%2FS1086-5802%2815%2930354-5

7 January 2021

Dependence and tolerance with zolpidem

1 reference

https://api.crossref.org/works/10.1016%2FS1086-5802%2815%2930354-5

7 January 2021

Possible interactions between zolpidem, a new sleep inducer and chlorpromazine, a phenothiazine neuroleptic.

1 reference

https://api.crossref.org/works/10.1016%2FS1086-5802%2815%2930354-5

7 January 2021

Rifampin reduces plasma concentrations and effects of zolpidem.

1 reference

https://api.crossref.org/works/10.1016%2FS1086-5802%2815%2930354-5

7 January 2021

Behavioral pharmacology of zolpidem relative to benzodiazepines: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1086-5802%2815%2930354-5

7 January 2021

A placebo-controlled evaluation of single, escalating doses of CL 284,846, a non-benzodiazepine hypnotic.

1 reference

https://api.crossref.org/works/10.1016%2FS1086-5802%2815%2930354-5

7 January 2021

Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo.

1 reference

https://api.crossref.org/works/10.1016%2FS1086-5802%2815%2930354-5

7 January 2021

Metabolism of Zaleplon by human hepatic microsomal cytochrome P450 isoforms.

1 reference

https://api.crossref.org/works/10.1016%2FS1086-5802%2815%2930354-5

7 January 2021

Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1086-5802%2815%2930354-5

7 January 2021

Trazodone for antidepressant-associated insomnia.

1 reference

https://api.crossref.org/works/10.1016%2FS1086-5802%2815%2930354-5

7 January 2021

Paroxetine in the treatment of primary insomnia: preliminary clinical and electroencephalogram sleep data.

1 reference

https://api.crossref.org/works/10.1016%2FS1086-5802%2815%2930354-5

7 January 2021

The effect of valerian extract on sleep polygraphy in poor sleepers: a pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS1086-5802%2815%2930354-5

7 January 2021

Sleep-inducing effects of low doses of melatonin ingested in the evening.

1 reference

https://api.crossref.org/works/10.1016%2FS1086-5802%2815%2930354-5

7 January 2021

Comparison of melatonin products against USP's nutritional supplements standards and other criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1086-5802%2815%2930354-5

7 January 2021